SOSV is a global venture capital firm offering multi-stage investment and early-stage startup development programmes focused on human and planetary health.
Portfolio
4
companies
Scindo
Scindo builds a data-driven artificial intelligence platform to design next-generation enzymes for sustainable chemistry.
Q5D
Q5D develops robotic cells that automate product electrification and eliminate manual wiring assembly.
QV Bioelectronics
QV Bioelectronics builds surgically implanted electric field therapy devices to treat brain tumours.
Motion Metrics
Motion Metrics develops digital coaching hardware and software for skiers.
Bill Liao
General Partner
The funding was co-led by Kadmos Capital and Clay Capital to expand the company's enzyme engine and wet-lab capabilities.
"Scindo represents exactly the type of company we seek to back – one that combines data-driven approaches with strong technical talent to address sustainability challenges,"
The financing round and grant package was co-led by Lockheed Martin Ventures, Chrysalix, and Maven SWIF.
"Our investment in Q5D and its automated electrification technology highlights our dedication to fostering a robust and resilient defense industrial base. Through investments like this one, Lockheed Martin Ventures aims to accelerate the development of next-generation technologies that will enable our customers to stay ahead of emerging threats and maintain a strategic advantage in an increasingly complex security landscape."
The pre-series a financing was led by Science Angel Syndicate and Fink Family Office to support pre-clinical studies for the GRACE implant.
The oversubscribed round was backed by Consilience Ventures, SOSV, and Catapult Ventures to support the development of the GRACE device.
"This investment is a vote of confidence in QV Bioelectronics from sector-expert investors. The funds raised will fuel the next phase of development of the GRACE device, allowing the size of the QV Bioelectronics team to grow in the process. This will take our innovative electric field therapy technology a few steps closer towards the clinic."
The Series A round was led by Artesian Investments to expand the digital instruction platform.
"This investment represents an incredibly exciting step towards our vision to become the de facto product to improve skiing technique. Skiing is a difficult sport to learn, and 88% of skiers stop lessons after less than 1 week – Carv offers a convenient and fun experience to continue learning. The pandemic has only accelerated the adoption of Carv’s digital ski instruction with us seeing over a 100% year-on-year growth for 2020 Q4. We are excited to be rapidly expanding our user base as the additional data helps us build an ever better coaching system. We are proud to welcome back our existing investors and see their continued support for our vision to deliver digital sports coaching. This is just the start for Carv, and we look forward to the next stage of growth and innovation."
